SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors. - Liu NQ; Paassen I; Custers L; Zeller P; Teunissen H; Ayyildiz D; He J; Buhl JL; Hoving EW; van Oudenaarden A; de Wit E; Drost J (Nature communications, 2023)